It’s End­points News' is­sue #100: The new dai­ly biotech pub now has a lit­tle his­to­ry

Cologne, Ger­many — We’ve hit our first big mile­stone here at End­points News. To­day marks our 100th is­sue, brought to you from Ger­many, where I’ve been spend­ing a few days at Bio-Eu­rope with a few thou­sand of my clos­est friends and read­ers.

Over the past few months, my part­ner, Ar­salan Arif, and I have been re­fin­ing a unique ap­proach to biotech news, fo­cus­ing on the ups and downs that in­flu­ence the glob­al in­dus­try with the unique per­spec­tive you get from 14 years in the front lines of this busi­ness. Biotech has changed a lot in just the last few years, and it’s been a lot of fun forg­ing our cov­er­age of the field.

This article is for premium subscribers only

Upgrade to a premium subscription plan for unlimited access, and join our community of key biopharma players.

UPGRADE